Will Boehringer give Yuhan Corporation ‘Jardiance’?
As ‘Jardiance(generic name: empagliflozin),’ a SGLT-2 inhibitor, is anticipated to receive the insurance benefit in the 1st half of the year at the latest, the industry has paid attention on which company will become the partnering company for the co-promotion.
Although Yuhan Corporation was a s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
